Hey 👋 We’re Ayaan and Rahul — Stanford CS dropouts who’ve exited 3 startups together.

Our 4th startup is Convexia, an AI-maximalist pharma company. We buy drugs, run clinical trials, and then sell for profit.

🎥 Launch Video

Problem

Pharma is the most bloated, antiquated trillion-dollar industry on the planet.

Life-saving drugs are overlooked, abandoned, or shelved because diligence is still done by hand. Slow, costly, and outdated.

Our Solution

We use agents to operate 10x faster and 20x leaner. Convexia’s AI agents autonomously handle:

• Sourcing – Find hidden early-stage drugs from around the world.
• Scientific diligence – Evaluate drug viability with leading computational biology tools
• Market analysis – Model market size, competition, and IP positioning
• Clinical operations – Simulate trials, flag CMC issues, and discover CROs
• Business development – Match each drug to the right buyer

Test our agents here: https://www.convexia.bio/playground

Our Ask

Before buying and selling drugs ourselves, we are running pilots with early customers who want to accelerate their search and evaluation processes.

📅 Book a call here.

Here’s who we’re looking to meet—see if anyone’s in your network here.

• Small/mid pharma companies (Incyte, Nimbus, Roivant SubCos)
• Biotech VCs (Versant, Atlas, RA Capital)
• Computational biotechs (Recursion, Insitro, Owkin)
• Operators who’ve brought drugs to market

Reach us: founders@convexia.bio